Selection marker-free recombinant goat-pox virus for expression of Orf virus F1L protein and construction method thereof

A goat pox virus and screening marker technology, applied in the field of molecular biology, can solve the problems of ineffective proliferation, mosaic phenomenon, off-target phenomenon, etc., and achieve the effect of easy grasp of the timing of virus collection, simple and effective method, and controllable spot picking time

Inactive Publication Date: 2020-01-24
CHONGQING ACAD OF ANIMAL SCI
View PDF3 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, this is still a problem for the industry
Guo Fei et al. from the Institute of Pathogen Biology, Chinese Academy of Medical Sciences (A vaccinia virus vector with high efficiency recombination and no selection marker and its establishment method, CN201910370701.7, 2019-07-19.) used CRISPR-Cas9 technology to knock out vaccinia virus The TK gene is then labeled with eGFP fluorescence on the poxvirus, and then the marker gene is deleted using the Cre-LoxP system. Although the efficiency of homologous recombination has been improved, there are the following disadvantages: (1) CRISPR-Cas9 is an emerging technology in recent years. At this stage, we mainly face problems such as low precision repair ratio, limitation of PAM recognition sequence, off-target phenomenon, mosaic phenomenon, etc. Many aspects still need to be continuously improved and perfected; (2) In the process of constructing unmarked recombinant poxvirus, gene editing After the technology, it still needs to go through multiple plaque purification screenings, which does not simplify the virus purification process, and the purification of recombinant viruses is the key to obtaining recombinant viruses
[0008] CN 102559611A discloses a double-expression recombinant MVA virus without screening markers and its construction method, in which homologous recombination technology and terminal dilution method are used to construct and screen marker-free recombinant viruses, but it has the following disadvantages: First, the selected Ankara The vaccinia virus (MVA) vector cannot effectively proliferate in the human body and most mammalian cells. The use of hamster kidney cells (BHK21) for liposome transfection to construct recombinant MVA virus will inevitably affect the efficiency of homologous recombination, which will affect the construction of recombinant virus. Second, in the process of constructing the recombinant virus, the target gene was not marked, resulting in the inability to visually and effectively distinguish the recombinant virus from the parental virus, making the purification and identification of the recombinant virus very difficult, which is why most of the current research The difficult problem to be overcome in constructing the recombinant virus containing the screening marker gene, and the paper does not give a more effective solution; then, in the purification process of the recombinant virus, the BHK21 cells are replaced by rabbit kidney cells (RK-13), However, the proliferation of viruses on new cell lines requires an adaptation period, which increases the difficulty of virus purification, and the use of endpoint dilution method to obtain recombinant viruses requires a greater workload and is prone to false positives.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Selection marker-free recombinant goat-pox virus for expression of Orf virus F1L protein and construction method thereof
  • Selection marker-free recombinant goat-pox virus for expression of Orf virus F1L protein and construction method thereof
  • Selection marker-free recombinant goat-pox virus for expression of Orf virus F1L protein and construction method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] Construction of pUC19-lateP-earlyP-eGFP recombinant plasmid

[0043] 1. Design of the target gene sequence

[0044] The sequence of the target gene is composed of upstream homology arm, late promoter, polyclonal restriction site, early promoter, eGFP, and downstream homology arm. The full length of the gene is 2 712bp.

[0045] 1.1 Sequence information of the upstream homology arm: the size is 906 bp, and a SphI restriction site is inserted at the 5' end of SEQ ID NO: 1.

[0046] 1.2 Sequence information of late promoter and early promoter: the size is 44bp (1-44 base site in SEQ ID NO:2) and 39bp (1-39bp in SEQ ID NO:3) respectively, the 3' end of late promoter Insert Sal I SmaI AfIII NarIBspMI BamHI ApaI NheI SacII KpnI, HindIII polyclonal restriction site (45-114bp in SEQ ID NO:2), insert Xho I restriction site at the 3' end of early promoter (SEQ ID NO:3 medium 40-46bp).

[0047] SEQ ID NO: 2

[0048]

[0049] SEQ ID NO: 3

[0050] 1AAGCTCGTAA AAGTAGAAAA TAT...

Embodiment 2

[0056] Construction, Purification and Identification of rGTPV-eGFP Recombinant Sheeppox Virus Stably Expressing Green Fluorescent Protein

[0057] Construction of recombinant virus

[0058] 1. Recombinant plasmid extraction: The pUC19-lateP-earlyP-eGFP recombinant plasmid was extracted using the endotoxin-free medium plasmid extraction kit HiPurePlasmind Midiprep Kit from Invitrigen, and stored at -20°C for later use. 2. Cell culture and inoculation: Take a 6-well culture plate, add 2 mL of BHK21 cells to each well, the content is 1-2 × 105 cells, culture at 37°C with 5% CO2, and when it reaches 80% confluence, inoculate sheeppox attenuated cells. Vaccine strain, the virus inoculation amount is 0.05 MOI, and a blank control is set, incubate at 37°C for 2h, change the maintenance medium (without antibiotics), and continue to cultivate for 4h;

[0059] 3. Preparation of transfection solution: To prepare 250 μL of A solution, the specific steps are as follows: Mix 240 μL of OPTI...

Embodiment 3

[0067] Construction and Identification of Recombinant Plasmid pUC19-lateP-earlyP-F1L

[0068] 1. Amplification of the F1L target gene: Use the virus genome extraction kit to extract the ORFV genome as a template and F1L-F / F1L-R as primers to amplify the F1L full-length gene sequence. The PCR reaction system is: DNA template 2μL, primers F1L-F / F1L-R (10pmol / μL) 0.5μL each, 2×Taq MasterMix 10μL, ddH2O to make up to 20μL, reaction conditions: 94°C for 5min; 94°C for 40sec, 55°C 40sec, 72°C 40sec, 30 cycles in total; 72°C extension for 10min; After the reaction was completed, it was identified and analyzed by agarose gel electrophoresis, and the expected band appeared at about 1000bp (see Figure 4) .

[0069] Seq ID NO.9(F1L-F): 5'-CCG CTCGAG ATGGATCCACCCGAAATC-3'

Seq ID NO. 10 (F1L-R): 5'-TGC TCTAGA TCACACGATGGCCGTGAC-3'

[0070] F1L-F are underlined XhoI restriction sites.

[0071] F1L-R underlined is the XbaI restriction site.

[0072] 2. C...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Through homologous recombination and by innovative utilization of plaque and reverse plaque screening technologies, the selection marker-free recombinant virus, especially the rGTPV-F1L recombinant goat-pox virus is finally obtained. The method is simple and effective, is easy to operate, provides the selection marker-free recombinant virus for the development of a recombinant virus vaccine, provides new ideas and measures for the researches on a novel ORF vaccine, and has broad application prospects.

Description

technical field [0001] The invention belongs to the field of molecular biology, in particular to a recombinant virus, and more particularly to a recombinant goat pox virus without a selection marker and a construction method thereof. Background technique [0002] Orf, also known as Contagious Ecthyma (CE), is a zoonotic disease caused by Orfvirus (ORFV). One of the most important viral diseases affecting goats and sheep. The disease mainly affects the lips, tail bases and breasts of sheep, and often leads to symptoms such as pustules, ulcers and nodules at the infected site. The disease spreads rapidly, is widespread, and has a high incidence rate. Sheep of different breeds, genders and ages can be infected. The morbidity and mortality rate is the highest in lambs. Due to the good tropism of ORFV on the lips of lambs, lambs are affected. Posterior lip wounds are often secondary to infection with a variety of pathogens, resulting in difficulty in eating, decreased immunity,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N7/01C12N15/863A61K39/275A61P31/20C12R1/93
CPCC12N7/00C12N15/86A61K39/12A61P31/20C12N2710/24221C12N2710/24243C12N2710/24252C12N2710/24234A61K2039/5256A61K2039/552
Inventor 许国洋杨柳余远迪沈克飞付利芝白运川
Owner CHONGQING ACAD OF ANIMAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products